1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

Addison's disease

  1. Hematopoietic neoplastic diseases develop in C3H/He and C57BL/6 mice after benzene exposure: strain differences in bone marrow tissue responses observed using microarrays.
  2. [Study on the relationship between polymorphisms of Cyp1A1, GSTM1, GSTT1 genes and the susceptibility to acute leukemia in the general population of Hunan province]
  3. Will Jill come tumbling after? The case for a JAK2-type mutation as a prequel to the connective tissue disorders.
  4. Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendations.
  5. Impaired S-phase arrest in acute myeloid leukemia cells with a FLT3 internal tandem duplication treated with clofarabine.
  6. Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia.
  7. The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure.
  8. [Bioinformatic analysis and identification for a novel antigen MLAA-22 in acute monocytic leukemia]
  9. Total body irradiation plus cyclophosphamide versus busulphan with cyclophosphamide as conditioning regimen for patients with leukemia undergoing allogeneic stem cell transplantation: a meta-analysis.
  10. Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required.
  11. [Relationship between the long type PML-RAR alpha and the prognosis of patients with acute promyelocytic leukemia]
  12. [Biphenotypic acute leukaemia with Burkitt-like cytology]
  13. A robust error model for iTRAQ quantification reveals divergent signaling between oncogenic FLT3 mutants in acute myeloid leukemia.
  14. Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML.
  15. ITD- and FL-induced FLT3 signal transduction leads to increased C/EBPbeta-LIP expression and LIP/LAP ratio by different signalling modules.
  16. Idarubicin plus behenoyl cytarabine and 6-thioguanine compares favorably with idarubicin plus cytarabine-based regimen for children with previously untreated acute myeloid leukemia: 10-year retrospective, multicenter study in Korea.
  17. The development of a three-dimensional scaffold for ex vivo biomimicry of human acute myeloid leukaemia.
  18. A novel variant translocation t(6;8;21)(p22;q22;q22) leading to AML/ETO fusion in acute myeloid leukemia.
  19. Early development of acute myeloid leukemia following treatment of osteosarcoma: a case report and review of the literature.
  20. Incidence and susceptibility to therapy-related myeloid neoplasms.